Diseases, Conditions, Syndromes

Blow to global vaccine drive as Pfizer delays deliveries

A global coronavirus vaccine rollout suffered a major blow Friday as Pfizer said it would delay shipments of the jabs in the next three to four weeks due to works at its key plant in Belgium.

Health

Soviet-era pill from Bulgaria helps smokers quit

(AP) -- A pill developed in Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big study of it shows.

Medical economics

GSK, Pfizer to merge consumer healthcare units

Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines.

Vaccination

Pfizer says COVID-19 vaccine will cost $110-$130 per dose

Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free.

Other

Pfizer sees Covid-19 drug sales topping $50 bn in 2022

Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.

Medications

Pfizer's blockbuster drug Lipitor goes generic

Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on Wednesday, opening the path to generic competitors for America's most popular medication.

Oncology & Cancer

Faulty gene connected to ovarian cancer risk

In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expected ...

page 4 from 40